David San Segundo Arribas
Overview
Explore the profile of David San Segundo Arribas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
9
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Luis S, Comins-Boo A, Perez-Pla F, Irure-Ventura J, Insunza Gaminde A, Lopez-Hoyos M, et al.
Clin Chem Lab Med
. 2024 Nov;
PMID: 39543980
Objectives: CD34+ hematopoietic stem cell (HSC) enumeration, crucial for HSC transplantation, is performed by flow cytometry to guide clinical decisions. Variability in enumeration arises from biological factors, assay components, and...
2.
Gonzalez-Lopez E, Ocejo-Vinyals J, Renuncio-Garcia M, Roa-Bautista A, San Segundo Arribas D, Escagedo C, et al.
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893114
Kidney transplantation is the preferred therapeutic option for end-stage renal disease; however, the alloimmune response is still the leading cause of renal allograft failure. To better identify immunologic disparities in...
3.
Comins-Boo A, Perez-Pla F, Irure-Ventura J, Lopez-Hoyos M, Blanco-Peris L, Martin Alonso M, et al.
Clin Chem Lab Med
. 2023 Aug;
62(2):312-321.
PMID: 37548423
Objectives: Flow cytometry analyses of lymphocyte subpopulations (T, B, NK) are crucial for enhancing clinical algorithms and research workflows. Estimating the total error (TE) values for the percentage and absolute...
4.
Roa-Bautista A, Lopez-Duarte M, Paz-Gandiaga N, San Segundo Arribas D, Ocejo-Vinyals J
EJIFCC
. 2023 Jan;
33(4):325-333.
PMID: 36605301
Herein we described a retrospective analysis of a 13-year-old female patient with facial dysmorphia and immune disorder caused by BCL11B gene mutation. The patient upon physical examination presented a particular...
5.
de Cos Gomez M, Benito Hernandez A, Garcia Unzueta M, Mazon Ruiz J, Lopez Del Moral Cuesta C, Perez Canga J, et al.
J Clin Med
. 2021 Jan;
9(12).
PMID: 33419237
Kidney transplantation implies a significant improvement in patient survival. Nevertheless, early mortality after transplant remains high. Growth differentiation factor 15 (GDF-15) is a novel biomarker under study as a mortality...
6.
Lopez Del Moral Cuesta C, Guiral Foz S, Gomez Pereda D, Perez Canga J, de Cos Gomez M, Mazon Ruiz J, et al.
Biomedicines
. 2020 Apr;
8(4).
PMID: 32231087
Immunosuppression withdrawal after graft failure seems to favor sensitization. A high percentage of calculated panel-reactive antibody (cPRA) and the development of de novo donor specific antibodies (dnDSA) indicate human leukocyte...
7.
Belmar Vega L, San Segundo Arribas D, Irure Ventura J, Hoyos M, Fernandez Fresnedo G, Rodrigo Calabria E, et al.
Nefrologia (Engl Ed)
. 2019 Dec;
40(5):569.
PMID: 31818500
No abstract available.
8.
Belmar Vega L, Hoyos M, San Segundo Arribas D, Irure Ventura J, Fernandez Fresnedo G, Ruiz San Millan J, et al.
Nefrologia (Engl Ed)
. 2019 May;
39(4):436-438.
PMID: 31103244
No abstract available.